Publication Year: 2023
-
Budget Impact of a Blood-Based Integrated Classifier Test to Reclassify Risk of Pulmonary Nodules in a US Commercial Payer Setting
-
Budget Impact of a Blood-Based Integrated Classifier Test to Down Classify Riskof Pulmonary Nodules in a US Medicare Payer Setting
-
Shifting the Intervention Probability Curve for Lung Cancer Diagnosis Following Biomarker Implementation: A Novel Clinical Endpoint for Biomarker Clinical Trials
-
Development of new droplet digital PCR method for MSI assessment with automated analysis pipeline shows concordance in FFPE and plasma
-
Real-world demographics, baseline characteristics, healthcare resource utilization and costs amongst non-small cell lung cancer (NSCLC) patients tested with a Host Immune Classifier (HIC)
-
Evaluation of two clinically focused targeted NGS systems for liquid biopsy testing shows a high level of concordance in resulting actionable mutations
-
Prevalence of four major gene mutation classes in a survey of ctDNA recovery from early and advanced stage NSCLC specimens